Desloratadine critrate disodium particles and preparation method for same

A technology of loratadine and citrate, which is applied in the field of desloratadine citrate granules and its preparation, can solve problems such as difficulty in swallowing, sticking in the throat, becoming sticky, etc., and achieves high bioavailability, bright red color and attractive People, the effect of good taste of the solution

Inactive Publication Date: 2012-07-04
YANGTZE RIVER PHARM GRP GUANGZHOU HAIRUI PHARM CO LTD
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The absorption of tablets in the body must go through processes such as disintegration and dissolution before they can be absorbed into the blood circulation. However, in the production process of tablets, it is often difficult to disintegrate due to excipients and processes, and the drug release is not complete, so that the drug cannot achieve the expected therapeutic effect. Effect
Capsules are mainly composed of gelatin, which will become sticky when exposed to water, and tend to stick in the mouth when taking it, making it difficult to swallow
[0004] Due to the incomplete development of various body organs and poor swallowing ability of children, when taking tablets and capsules, it is very easy for capsules and tablets to block the trachea or get stuck in the throat.
And because most medicines have obvious bitter taste, it is not easy to be accepted by children, most parents use the method of forced irrigation, which is very likely to cause the child's tracheal blockage and cause danger

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Desloratadine critrate disodium particles and preparation method for same
  • Desloratadine critrate disodium particles and preparation method for same
  • Desloratadine critrate disodium particles and preparation method for same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] This embodiment prepares 1000 bags of desloratadine citrate granules, and the composition of each raw material is as follows:

[0045]

[0046]

[0047] The desloratadine citrate granules of the present embodiment are prepared according to the following method:

[0048] a. The raw material desloratadine citrate is passed through a 100-mesh sieve, and the filler, sweetener, pH regulator, flavor and food coloring are respectively passed through a 80-mesh sieve, and the above raw materials are weighed in proportion for use;

[0049] b. Mix the raw materials weighed in step a by the equal-increment method, use pure water to prepare soft materials, and pass through a 16-mesh sieve to prepare granules;

[0050] c. Dry the granules obtained in step b at 60° C. until the moisture content is lower than 2.0%, and pass through a 10-mesh sieve to obtain the deslorat granules.

Embodiment 2

[0052] This embodiment prepares 1000 bags of desloratadine citrate granules, and the composition of each raw material is as follows:

[0053]

[0054]

[0055] The preparation method of desloratadine citrate granules in this example is the same as that in Example 1.

Embodiment 3

[0057] This embodiment prepares 1000 bags of desloratadine citrate granules, and the composition of each raw material is as follows:

[0058]

[0059] The preparation method of desloratadine citrate granules in this example is the same as that in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses desloratadine critrate disodium particles. Based on 100 percent, the desloratadine critrate disodium particles comprise the following raw materials in percentage by weight: 0.1 to 2 percent of desloratadine critrate disodium, 20 to 90 percent of filler, 1 to 10 percent of sweetener, 0.1 to 5 percent of PH conditioner, 0.1 to 2 percent of essence and 0 to 0.05 percent of food coloring, wherein the desloratadine critrate disodium serves as an active ingredient; and the filler, the sweetener, the PH conditioner, the essence and the food coloring serve as minor ingredients. The prepared desloratadine critrate disodium particles have good mouth-feel, and are fresh red, attractive, convenient to take, fast in absorption and high in bioavailability; and a child can compliantly take the particles.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to desloratadine citrate granules and a preparation method thereof. Background technique [0002] Desloratadine citrate is a non-sedating long-acting histamine antagonist with potent and selective antagonism of peripheral H, receptor action and anti-inflammatory effects. It is mainly used for the rapid relief of symptoms related to allergic rhinitis (allergic rhinitis), such as sneezing, runny nose, and itchy nose; congestion / stuffiness of nasal mucosa; and itchy, tearing, and congestion of eyes; itchy palate, and cough. It is also used to relieve symptoms associated with chronic idiopathic urticaria, such as itching, and to reduce the number and size of urticaria. [0003] Currently, the dosage forms for clinical selection mainly include tablets, capsules and the like. The absorption of tablets in the body must go through processes such as disintegration and dissolution before...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K31/4545A61P11/02A61P37/08
Inventor 李继仁杨青海
Owner YANGTZE RIVER PHARM GRP GUANGZHOU HAIRUI PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products